A cardiotoxicity dataset for breast cancer patients.


Journal

Scientific data
ISSN: 2052-4463
Titre abrégé: Sci Data
Pays: England
ID NLM: 101640192

Informations de publication

Date de publication:
08 08 2023
Historique:
received: 08 05 2023
accepted: 26 07 2023
medline: 10 8 2023
pubmed: 9 8 2023
entrez: 8 8 2023
Statut: epublish

Résumé

This dataset is a result of the collaboration between the University of A Coruña and the University Hospital of A Coruña. It contains information about 531 women diagnosed with HER2+ breast cancer, treated with potentially cardiotoxic oncologic therapies. These treatments can cause cardiovascular adverse events, including cardiac systolic dysfunction, the development of which has important clinical and prognostic implications. The availability of good predictors may enable early detection of these cardiac problems. Variables such as age, weight and height are available for each patient, as well as some measures obtained from echocardiography, a technique used prior and during the treatment to check the structure and function of the heart. Among them, there is a functional variable that measures the myocardial velocity during the cardiac cycle. For patients that experienced cancer therapy-related cardiac dysfunction during the treatment period, time until its appearance is known. This dataset aims to enable the scientific community in conducting new research on this cardiovascular side effect.

Identifiants

pubmed: 37553506
doi: 10.1038/s41597-023-02419-1
pii: 10.1038/s41597-023-02419-1
pmc: PMC10409791
doi:

Substances chimiques

Antineoplastic Agents 0

Types de publication

Dataset Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

527

Informations de copyright

© 2023. Springer Nature Limited.

Références

J Clin Med. 2019 Feb 18;8(2):
pubmed: 30781624
Cardiol Clin. 2019 Nov;37(4):419-427
pubmed: 31587783
BMC Cardiovasc Disord. 2016 Apr 22;16:72
pubmed: 27102111
Breast Cancer Res Treat. 2021 Jul;188(1):21-36
pubmed: 34115243
Cardiooncology. 2018 Sep 03;4:6
pubmed: 32154006
Sci Data. 2023 Aug 8;10(1):527
pubmed: 37553506
Breast Cancer Res Treat. 2009 Sep;117(2):357-64
pubmed: 19082707
Eur Heart J. 2022 Nov 1;43(41):4229-4361
pubmed: 36017568

Auteurs

Beatriz Piñeiro-Lamas (B)

Grupo MODES, Departamento de Matemáticas, CITIC, Universidade da Coruña, A Coruña, 15071, Spain. b.pineiro.lamas@udc.es.

Ana López-Cheda (A)

Grupo MODES, Departamento de Matemáticas, CITIC, Universidade da Coruña, A Coruña, 15071, Spain.

Ricardo Cao (R)

Grupo MODES, Departamento de Matemáticas, CITIC, Universidade da Coruña, A Coruña, 15071, Spain.

Laura Ramos-Alonso (L)

Servicio de Medicina Interna, Complexo Hospitalario Universitario de A Coruña, A Coruña, 15006, Spain.

Gabriel González-Barbeito (G)

Unidad de Imagen y Función Cardíaca, Servicio de Cardiología, Complexo Hospitalario Universitario de A Coruña, Instituto de Investigación Biomédica de A Coruña (INIBIC), A Coruña, 15006, Spain.

Cayetana Barbeito-Caamaño (C)

Unidad de Imagen y Función Cardíaca, Servicio de Cardiología, Complexo Hospitalario Universitario de A Coruña, Instituto de Investigación Biomédica de A Coruña (INIBIC), A Coruña, 15006, Spain.

Alberto Bouzas-Mosquera (A)

Unidad de Imagen y Función Cardíaca, Servicio de Cardiología, Complexo Hospitalario Universitario de A Coruña, Instituto de Investigación Biomédica de A Coruña (INIBIC), A Coruña, 15006, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH